Healthcare -
Biotechnology - NASDAQ - US
$ 39.24
4.39 %
$ 2.41 B
Market Cap
9.28
P/E
PTGX - CASH FROM OPERATIONS
Cash from Operations PTGX - Protagonist Therapeutics, Inc.
-70.2 M
LAST VALUE
19.31%
2 YEAR CAGR
-7.06%
5 YEAR CAGR
0.00%
10 YEAR CAGR